Statement of Cash Flows (التدفقات النقدية)
Indirect IAS 7
Trial BalanceProfit & LossMulti-Branch P&LBalance SheetCash FlowEgypt VAT ReturnDeferred PackagesCash vs Accrual Bridge
Opening Cash & Banks
EGP 2,735,800
GL 1110 + 1120 + 1130 + 1140
Operating Cash Inflow
EGP 922,692.60
Cash Positive
Investing & Financing
EGP 0
Capex 1510 & Loan 2410
Closing Cash Position
EGP 3,658,492.60
Net Change: +EGP 922,692.60
| Cash Flow Activity | Amount (EGP) |
|---|---|
| 1. Cash Flows from Operating Activities | |
| Accrual Net Operating Profit (from P&L) | EGP 637,590 |
| Add Back: Non-Cash Equipment Depreciation (GL 6280) | EGP 0 |
| Working Capital Movements (VAT Collected 2310, Inventory 1310, Deferred Packages 2210, Wallets 2220) | EGP 285,102.60 |
| Net Cash Provided by Operating Activities | EGP 922,692.60 |
| 2. Cash Flows from Investing Activities | |
| Acquisitions of Medical Laser Devices & Clinic Fit-Out (GL 1510) | EGP -0 |
| Net Cash Used in Investing Activities | EGP -0 |
| 3. Cash Flows from Financing Activities | |
| Equipment Leasing & Bank Loan Principal Repayments / Drawdowns (GL 2410) | EGP 0 |
| Net Cash from Financing Activities | EGP 0 |
| Net Increase / (Decrease) in Cash & Equivalents | EGP 922,692.60 |
| Cash, Corporate Banks & Clearing at Beginning of Period | EGP 2,735,800 |
| Cash, Corporate Banks & Clearing at End of Period | EGP 3,658,492.60 |